Health ❯Healthcare ❯Patient Safety

Adverse Effects

Clinical Research Medical Research Patient Safety Weight Management Neurology Regenerative Medicine Research Studies Infectious Diseases Cell Biology Stock Market

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

Sarepta is enlisting experts to design a stronger immunosuppressive regimen.

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Stem Cell Therapies for Parkinson’s Show Safety and Early Effectiveness in Trials

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns